Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease

Dopaminergic cell death in the substantia nigra (SN) is central to Parkinson's disease (PD), but the neurodegenerative mechanisms have not been completely elucidated. Iron accumulation in dopaminergic and glial cells in the SN of PD patients may contribute to the generation of oxidative stress, protein aggregation, and neuronal death. The mechanisms involved in iron accumulation also remain unclear. Here, we describe an increase in the expression of an isoform of the divalent metal transporter 1 (DMT1/Nramp2/Slc11a2) in the SN of PD patients. Using the PD animal model of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) intoxication in mice, we showed that DMT1 expression increases in the ventral mesencephalon of intoxicated animals, concomitant with iron accumulation, oxidative stress, and dopaminergic cell loss. In addition, we report that a mutation in DMT1 that impairs iron transport protects rodents against parkinsonism-inducing neurotoxins MPTP and 6-hydroxydopamine. This study supports a critical role for DMT1 in iron-mediated neurodegeneration in PD.

[1]  D. Richardson,et al.  Interferon-gamma and lipopolysaccharide regulate the expression of Nramp2 and increase the uptake of iron from low relative molecular mass complexes by macrophages. , 2000, European journal of biochemistry.

[2]  S. Przedborski,et al.  Oxidative Stress in Parkinson's Disease , 2008, Annals of the New York Academy of Sciences.

[3]  V. Uversky,et al.  Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure. , 2001, The Journal of biological chemistry.

[4]  M. L. Ujwal,et al.  Divalent metal-ion transporter DMT1 mediates both H+ -coupled Fe2+ transport and uncoupled fluxes , 2005, Pflügers Archiv.

[5]  Keiichiro Suzuki,et al.  Tumor necrosis factor-alpha-induced iron sequestration and oxidative stress in human endothelial cells. , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[6]  G. Reynolds,et al.  Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain , 2005, Journal of Neural Transmission.

[7]  Junxia Xie,et al.  Up‐regulation of divalent metal transporter 1 is involved in 1‐methyl‐4‐phenylpyridinium (MPP+)‐induced apoptosis in MES23.5 cells , 2008 .

[8]  Stephan Nussberger,et al.  Cloning and characterization of a mammalian proton-coupled metal-ion transporter , 1997, Nature.

[9]  B. Djahanguiri,et al.  The prevention of acute gastric ulcer in the rat by alpha-methyldopa. , 1967, Medicina et pharmacologia experimentalis. International journal of experimental medicine.

[10]  P. Thong,et al.  Dopaminergic cell death precedes iron elevation in MPTP-injected monkeys. , 2003, Free radical biology & medicine.

[11]  C. Piantadosi,et al.  TNF, IFN-γ, and endotoxin increase expression of DMT1 in bronchial epithelial cells , 2005 .

[12]  J. Drapier,et al.  Recycling of RNA Binding Iron Regulatory Protein 1 into an Aconitase after Nitric Oxide Removal Depends on Mitochondrial ATP* , 2002, The Journal of Biological Chemistry.

[13]  M. Vila,et al.  MPTP as a Mitochondrial Neurotoxic Model of Parkinson's Disease , 2004, Journal of bioenergetics and biomembranes.

[14]  M. Hentze,et al.  Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[15]  J. Connor,et al.  Cellular distribution of iron in the brain of the Belgrade rat , 1999, Neuroscience.

[16]  L. Murray-Kolb,et al.  Early iron deficiency alters sensorimotor development and brain monoamines in rats. , 2007, The Journal of nutrition.

[17]  Prasad N. Paradkar,et al.  Comparison of mammalian cell lines expressing distinct isoforms of divalent metal transporter 1 in a tetracycline-regulated fashion. , 2006, The Biochemical journal.

[18]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .

[19]  N. Andrews,et al.  Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene , 1997, Nature genetics.

[20]  Peter S. Freestone,et al.  Acute effects of 6-hydroxydopamine on dopaminergic neurons of the rat substantia nigra pars compacta in vitro. , 2005, Neurotoxicology.

[21]  Y. Ke,et al.  Age-dependent and iron-independent expression of two mRNA isoforms of divalent metal transporter 1 in rat brain , 2005, Neurobiology of Aging.

[22]  R. Burke,et al.  Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. , 1995, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.

[23]  E. Morgan,et al.  The significance of the mutated divalent metal transporter (DMT1) on iron transport into the Belgrade rat brain , 2003, Journal of neurochemistry.

[24]  Keiichiro Suzuki,et al.  Tumor Necrosis Factor-&agr;–Induced Iron Sequestration and Oxidative Stress in Human Endothelial Cells , 2005 .

[25]  A. Graybiel,et al.  Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease , 1988, Nature.

[26]  M. Hoehn,et al.  Parkinsonism , 1967, Neurology.

[27]  Y. Agid,et al.  Iron and Aluminum Increase in the Substantia Nigra of Patients with Parkinson's Disease: An X‐Ray Microanalysis , 1991, Journal of neurochemistry.

[28]  M. Mattson,et al.  Role of dietary iron restriction in a mouse model of Parkinson's disease , 2004, Experimental Neurology.

[29]  E. Hirsch,et al.  Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease , 1994, Neuroscience Letters.

[30]  L. Forno,et al.  Neuropathology of Parkinson's Disease , 1996, Journal of neuropathology and experimental neurology.

[31]  E. Hirsch,et al.  The density of [125I]-transferrin binding sites on perikarya of melanized neurons of the substantia nigra is decreased in Parkinson's disease , 1997, Brain Research.

[32]  E. Morgan,et al.  Transferrin and Iron Uptake by the Brain: Effects of Altered Iron Status , 1991, Journal of neurochemistry.

[33]  G. Weiss,et al.  Cytokine Mediated Regulation of Iron Transport in Human Monocytic Cells , 2003 .

[34]  M. Núñez,et al.  Iron dyshomeostasis in Parkinson's disease. , 2006, Journal of neural transmission. Supplementum.

[35]  M. Hentze,et al.  Previously uncharacterized isoforms of divalent metal transporter (DMT)-1: Implications for regulation and cellular function , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[36]  S. Shimohama,et al.  Dopamine D2‐type agonists protect mesencephalic neurons from glutamate neurotoxicity: Mechanisms of neuroprotective treatment against oxidative stress , 1998, Annals of neurology.

[37]  J. Connor,et al.  Distribution of divalent metal transporter-1 in the monkey basal ganglia , 2004, Neuroscience.

[38]  T. Patterson,et al.  Gene expression profiling of MPP+-treated MN9D cells: a mechanism of toxicity study. , 2007, Neurotoxicology.

[39]  M. Beal,et al.  Excitotoxicity and nitric oxide in parkinson's disease pathogenesis , 1998, Annals of neurology.

[40]  N. Andrews,et al.  Nramp2 is mutated in the anemic Belgrade (b) rat: evidence of a role for Nramp2 in endosomal iron transport. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[41]  C. Piantadosi,et al.  TNF, IFN-gamma, and endotoxin increase expression of DMT1 in bronchial epithelial cells. , 2005, American Journal of Physiology - Lung cellular and Molecular Physiology.

[42]  S. Hunot,et al.  Neuroinflammatory processes in Parkinson's disease , 2003, Annals of neurology.

[43]  Hermann-Josef Gröne,et al.  Iron regulatory proteins are essential for intestinal function and control key iron absorption molecules in the duodenum. , 2008, Cell metabolism.

[44]  C. Pert,et al.  Transferrin receptors in rat brain: neuropeptide-like pattern and relationship to iron distribution. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[45]  Hong Jiang,et al.  Up-regulation of divalent metal transporter 1 is involved in 1-methyl-4-phenylpyridinium (MPP+)-induced apoptosis in MES23.5 cells , 2009, Neurobiology of Aging.

[46]  S. Snyder,et al.  NMDA Receptor-Nitric Oxide Transmission Mediates Neuronal Iron Homeostasis via the GTPase Dexras1 , 2006, Neuron.

[47]  P. Gros,et al.  Distinct targeting and recycling properties of two isoforms of the iron transporter DMT1 (NRAMP2, Slc11A2). , 2006, Biochemistry.

[48]  Hiroshi Ohno,et al.  Alternative splicing regulates the subcellular localization of divalent metal transporter 1 isoforms. , 2002, Molecular biology of the cell.

[49]  Jochen Roeper,et al.  K-ATP channels promote the differential degeneration of dopaminergic midbrain neurons , 2005, Nature Neuroscience.

[50]  Subramanian Rajagopalan,et al.  Genetic or Pharmacological Iron Chelation Prevents MPTP-Induced Neurotoxicity In Vivo A Novel Therapy for Parkinson's Disease , 2003, Neuron.

[51]  R. Crystal.  Managed care for viruses , 1997, Nature Medicine.

[52]  M. Garrick,et al.  Non‐transferrin‐bound iron uptake in Belgrade and normal rat erythroid cells , 1999, Journal of cellular physiology.

[53]  E. Hirsch,et al.  The Role of Glial Reaction and Inflammation in Parkinson's Disease , 2003, Annals of the New York Academy of Sciences.